EYE 2.86% 18.0¢ nova eye medical limited

EYE Summary (August 2024): Incredibly Undervalued, page-118

  1. 16,311 Posts.
    lightbulb Created with Sketch. 4359
    Did he seriously suggest that 2RT was costing this company money and would require raising capital? I might have to take good old Tekky off ignore simply for a cheap laugh! Expenditure on 2RT is so minimal compared to sales of iTrack Advance units, and this is clearly displayed in the company's financial reports. A partnership with an external party is the intended way to fund 2RT, hence the impairment.

    Tekky mate, do a bit more research on this so you can actually post comments based on facts rather than parrot Stonks, and I might take you off ignore and engage in a discussion. Despite your inability to see anything in even a slightly positive way, especially when the facts warrant such a positive view, you're at least a bit more sufferable than Stonks, who is unable to post anything of even the slightest value.
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.